Health Bidding War Intensifies for Metsera’s PD-(L)1xVEGF Bispecific Drug The competitive landscape for the PD-(L)1xVEGF bispecific drug has intensified as several pharmaceutical companies engage in a heated bidding war for Metsera. This development... Editorial3 hours ago
Science Adolescent Patients Gain Access to New Oral Psoriasis Treatment Patients aged 12 and older are set to benefit from the early inclusion of adolescents in pivotal clinical trials for the oral psoriasis treatment,... Editorial7 November, 2025